Hypervirulence and biofilm production in KPC-2-producing Klebsiella pneumoniae CG258 isolated in Brazil

References

1. Bassetti M, Giacobbe DR, Giamarellou H, Viscoli C, Daikos GL et al. Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect 2018; 24:133–144 [View Article][PubMed]
   [Google Scholar]
2. Labarca J, Poirel L, Ozdamar M, Turkoglü S, Hakko E et al. KPC-producing Klebsiella pneumoniae, finally targeting Turkey. New Microbes New Infect 2014; 2:50–51 [View Article][PubMed]
   [Google Scholar]
3. D'Andrea MM, Marmo P, Henrici de Angelis L, Palmieri M, Ciacci N et al. φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage. Sci Rep 2017; 7:2614 [View Article][PubMed]
   [Google Scholar]
4. Diago-Navarro E, Calatayud-Baselga I, Sun D, Khairallah C, Mann I et al. Antibody-based immunotherapy to treat and prevent infection with hypervirulent Klebsiella pneumoniae. Clin Vaccine Immunol 2017; 24:e00456-16 [View Article][PubMed]
   [Google Scholar]
5. Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp. phenotypes?. Virulence 2017; 8:1111–1123 [View Article][PubMed]
   [Google Scholar]
6. van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 2017; 8:460–469 [View Article][PubMed]
   [Google Scholar]
7. Cassat JE, Semltzer MS, Lee CY. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. MTDS Mol Biol 2014; 1085:195–211
   [Google Scholar]
8. de Campos PA, Royer S, Batistão DW, Araújo BF, Queiroz LL et al. Multidrug resistance related to biofilm formation in Acinetobacter baumannii and Klebsiella pneumoniae clinical strains from different pulsotypes. Curr Microbiol 2016; 72:617–627 [View Article][PubMed]
   [Google Scholar]
9. Saxena S, Banerjee G, Garg R, Singh M. Comparative study of biofilm formation in Pseudomonas aeruginosa isolates from patients of lower respiratory tract infection. J Clin Diagn Res 2014; 8:DC09–DC11 [View Article][PubMed]
   [Google Scholar]
10. Perez F, Villegas MV. The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria. Curr Opin Infect Dis 2015; 28:375–383 [View Article][PubMed]
    [Google Scholar]
11. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785–796 [View Article][PubMed]
    [Google Scholar]
12. Ribeiro PC, Monteiro AS, Marques SG, Monteiro SG, Monteiro-Neto V et al. Phenotypic and molecular detection of the bla_KPCgene in clinical isolates from inpatients at hospitals in São Luis, MA, Brazil. BMC Infect Dis 2016; 16:737 [View Article][PubMed]
    [Google Scholar]
13. Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD et al. A two-year surveillance in five colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother 2015; 60:332–342 [View Article][PubMed]
    [Google Scholar]
14. Pereira PS, de Araujo CF, Seki LM, Zahner V, Carvalho-Assef AP et al. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother 2013; 68:312–316 [View Article][PubMed]
    [Google Scholar]
15. Seki LM, Pereira PS, de Souza MP, Conceição MS, Marques EA et al. Molecular epidemiology of KPC-2- producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn Microbiol Infect Dis 2011; 70:274–277 [View Article][PubMed]
    [Google Scholar]
16. Lavigne JP, Cuzon G, Combescure C, Bourg G, Sotto A et al. Virulence of Klebsiella pneumoniae isolates harboring bla_KPC-2 carbapenemase gene in a Caenorhabditis elegans model. PLoS One 2013; 8:e67847 [View Article][PubMed]
    [Google Scholar]
17. Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 2015; 59:5873–5884 [View Article][PubMed]
    [Google Scholar]
18. Liu Y, Liu PP, Wang LH, Wei DD, Wan LG et al. Capsular polysaccharide types and virulence-related traits of epidemic KPC-Producing Klebsiella pneumoniae isolates in a Chinese University Hospital. Microb Drug Resist 2017; 23:901–907 [View Article][PubMed]
    [Google Scholar]
19. Gu D, Dong N, Zheng Z, Lin D, Huanf M et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2017; 3099:30489–9
    [Google Scholar]
20. Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 2014; 78:510–543 [View Article][PubMed]
    [Google Scholar]
21. Naparstek L, Carmeli Y, Navon-Venezia S, Banin E. Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 2014; 69:1027–1034 [View Article][PubMed]
    [Google Scholar]